Amyris Launches Terasana Clinical Clean Skincare Brand


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Amyris Launches Terasana Clinical Clean Skincare Brand
Latest Pharma News Update

Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of Terasana™ Clinical, a clean skincare brand. Today's launch represents the first of three highly anticipated brand launches Amyris will launch this summer.

Terasana Clinical's first skincare product, Clear + Control Healthy Skin Serum, addresses dry skin, skin flaking, irritation and redness with its moisturizing and anti-inflammatory properties which are designed to clear and balance the skin's appearance. Clear + Control Healthy Skin Serum is a patented formulation that combines two of Amyris' sustainably sourced ingredients, Squalane and Cannabigerol (CBG).

Squalane is Amyris' high-performance moisturizer that has demonstrated skin therapy benefits in clinical and consumer studies. It contributes to skin health by improving the skin's microbiome and enabling the penetration of cannabinoids and other skin care actives to enhance product performance. Amyris' CBG is a powerful anti-inflammatory and anti-microbial non-psychoactive (no THC) minor cannabinoid. Both Squalane and CBG are developed through Amyris' proprietary Lab-to-Market™ science and technology process.

A clinical study conducted with Clear + Control Healthy Skin Serum demonstrated a 92% reduction of blemishes after four weeks with results based on self-assessments by participants with dry skin, skin flaking, irritation, and redness. The study demonstrated that the anti-inflammatory and anti-microbial properties of CBG combined with Squalane improves and nourishes the skin by balancing the skin's microbiome. Compared to top competitive products that address acne and other common skin care issues, the Terasana Clinical formulation reduces inflammation more quickly and more effectively.

Dr Mamina Turegano MD, Triple-Board Certified Dermatologist and Terasana Clinical Brand Ambassador commented, "I am excited to be involved with Terasana Clinical. This is the only skincare brand I know of that combines highly effective, proven ingredients to clear blemishes and breakouts quickly while also nourishing the skin at the same time. The primary ingredients in Clear + Control Healthy Skin Serum, Squalane and CBG, are sustainably sourced and have been clinically tested. The innovative technology used to develop this product provides consumers a chance to experience clear skin with reduced concern for irritation or dryness."

"CBG has a variety of proven skin benefits and through our well-established fermentation technology, we are able to manufacture CBG at scale and at a much lower cost than existing alternatives," said John Melo, President and Chief Executive Officer of Amyris. "We believe that clean CBG has opened up new avenues for innovation in sustainable and effective skincare and that it has the potential to be a breakthrough in addressing the acne market. We are on track to launch three new clean beauty consumer brands this month which is a testament to the consistent performance and execution by our team. We continue to build on our current sales growth momentum in the third quarter and expect the new brands and consumer activity to contribute significant new revenue during the second half of this year."

Tags : #Amyris #Terasana #Skincarebrand #smitakumar #medicircle

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026
Dr. Reddy's Laboratories Launches Nationwide Educational Initiative to Strengthen India's Obesity Care WorkforceSeptember 14, 2026
IIM Bodh Gaya Hosts Convergence 3.0: The Next Frontier of Healthcare SectorSeptember 14, 2026
A Practical Guide to Fibre: How Indian Adults Can Add More Without Digestive DiscomfortSeptember 12, 2026
Understanding Heart Palpitations: Common Triggers, Helpful Records, and Warning SignsSeptember 12, 2026
The Fourth Trimester: Why Healthcare Often Stops Too Early After DeliverySeptember 12, 2026
Postpartum Mental Health: The Healthcare Gap Nobody Talks About EnoughSeptember 12, 2026
Fortis Escorts Faridabad Launches Region’s First Dedicated ‘Fever Clinic’ for Early Diagnosis and Timely TreatmentSeptember 11, 2026